Actinic keratosis

International Journal of Dermatology

Volumn 46, Issue 9, 2007, Pages 895-904

  Rossi, Riccardo ^a   Mori, Moira ^a   Lotti, Torello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; DICLOFENAC; ETRETIN; FLUOROURACIL; IMIQUIMOD; ISOTRETINOIN; PLACEBO; RETINOIC ACID; TRICHLOROACETIC ACID;

ACTINIC KERATOSIS; AGE DISTRIBUTION; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER GRADING; CARBON DIOXIDE LASER; CLINICAL TRIAL; CRYOSURGERY; CURETTAGE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISCOID LUPUS ERYTHEMATOSUS; DRUG EFFICACY; DYSKERATOSIS; ELECTROSURGERY; ENZYME INHIBITION; FEVER; HEADACHE; HUMAN; HYPERKERATOSIS; IRRITANT DERMATITIS; KERATOACANTHOMA; LENTIGO; LOW DRUG DOSE; NAUSEA; NEVUS; PAIN; PHOTODYNAMIC THERAPY; REVIEW; RISK FACTOR; SEBORRHEIC KERATOSIS; SEX DIFFERENCE; SKIN ABRASION; SKIN BIOPSY; SKIN SENSITIVITY; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUPERINFECTION; SWELLING; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; KERATOSIS; MALE; NEOPLASMS, SQUAMOUS CELL; PRECANCEROUS CONDITIONS; SKIN; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 34548534616     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03166.x     Document Type: Review

References (51)

1. Feldman SR, Fleischer AB Jr, McConnell C. Most common dermatologic problems identified by internists, 1990-1994. Arch Intern Med 1998; 158: 649-655.
2. Marks R, Jolley D, Dorevitsh AP, et al. The incidence of non-melanocytic skin cancer in an Australian population: Results of a five year prospective study. Med J Aust 1989; 150: 475-478.
3. Frost CA, Green AC. Epidemiology of solar keratoses. Br J Dermatol 1994; 151: 455-464.
4. Yantos VA, Conrad N, Azbawski E, et al. Incipient intraepidermal cutaneous squamous cell carcinoma: A proposal for reclassifying and grading solar (actinic) keratosis. Semin Cutan Med Surg 1999; 1: 3-14.
5. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 8-10.
6. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000; 115: 649-655.
7. Ackerman AB. Respect at last for solar keratosis. Dermatopathol: Pract Concept 1997; 3: 101-103.
8. Ortonne JP. From actinic keratosis to squamous cell carcinoma. Br J Dermatol 2002; 146: 20-23.
9. Schmook T, Stockfleth E. Current treatment patterns in non melanoma skin cancer across Europe. J Dermatol Treat 2003; 14: 3-10.
10. Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for actinic keratoses. J Am Acad Dermatol 1995; 32: 95-98.
11. Dodson JM, DeSpain J, Hewett JE, et al. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 1991; 127: 1029-1031.
12. Ilyas EN, Grana G, Green JJ. Inflammatory actinic keratoses secondary to systemic chemotherapy. Cutis 2005; 75: 167-168.
13. Dragieva G, Prinz BM, Hafner J, et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004; 151: 196-200.
14. Berking C, Takemoto R, Binder RL, et al. Photocarcinogenesis in human adult skin grafts. Carcinogenesis 2002; 23: 181-187.
15. Speight EL, Dahl MG, Farr PM. Actinic keratosis induced by use of sunbed. Br Med J 1994; 308: 415.
16. Diffey B. Climate change, ozone depletion and the impact on ultraviolet exposure of human skin. Phys Med Biol 2004; 49: R1-R11.
17. Yu RCH, Pryce DW, MacFarlane AQ, et al. A histopathological study of 643 cutaneous horns. Br J Dermatol 1991; 24: 449-452.
18. Butani A, Arbesfeld DM, Schwartz RA. Premalignant and early squamous cell carcinoma. Clin Plast Surg 2005; 32: 223-235.
19. Olsen EA, Abernethy ML, Kulp-Shorten C, et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 5: 738-743.
20. Yantos V. Continuous spectrum between actinic keratoses and SCC, analogous to CIN (cervical intraepithelial neoplasia). Semin Cutan Med Surg 1999; 18: 3-14.
21. Cockerell CJ. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000; 42: S11-S17.
22. Camacho Martinez F. Actinic keratosis. In: Katsambas AD, Lotti TM eds. European Handbook of Dermatological Treatments, 2nd edn. Berlin, Heidelberg, New York: Springer-Verlag: 2003: 10-15.
23. Feldman SR, Fleisher AB, Williford PM, et al. Destructive procedures are the standard of care for treatment of actinic keratoses. J Am Acad Dermatol 1999; 40: 43-47.
24. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratoses. Int J Dermatol 1996; 35: 533-538.
25. Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: An update and comparison. Dermatol Surg 2000; 26: 728-732.
26. Kuflik EG. Cryosurgery updated. J Am Acad Dermatol 1994; 31: 925-934.
27. Coleman WP, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratoses. Dermatol Surg 1996; 22: 17-21.
28. Iyer S, Friedli A, Bowes L, et al. Full face laser resurfacing: Therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer. Lasers Surg Med 2004; 34: 114-119.
29. Trimas SJ, Ellis DA, Metz RD. The carbon dioxide laser. An alternative for the treatment of actinically damaged skin. Dermatol Surg 1998; 24: 933-934.
30. Massey SA, Eliezri Y. A case report of laser resurfacing as a skin cancer prophylaxis. Dermatol Surg 1999; 25: 513-516.
31. Stulberg DL, Crandell B, Fawcett RS. Diagnosis and treatment of basal cell and squamous cell carcinomas. Am Fam Physician 2004; 70: 1481-1488.
32. Barta U, Grafe T, Wollina U. Radiation therapy for extensive actinic keratosis. J Eur Acad Dermatol 2000; 14: 293-295.
33. Eaglstein WH, Weinstein GD, Frost P. Fluorouracil: Mechanism of action in human skin and actinic keratoses, effect on DNA synthesis in vivo. Arch Dermatol 1979; 101: 132-139.
34. Robins P, Gupta AK. The use of topical fluorouracil to treat actinic keratosis. Cutis 2002; 70: 4-7.
35. Correale CE. AK: New treatment options. Adv Dermatol 2002; 18: 339-355.
36. Pearlman DL. Weekly pulse dosing: Effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses. J Am Acad Dermatol 1991; 25: 665-667.
37. Stockfleth E, Meyer T, Benninghoff B, et al. A randomized, double-blind, vehicle controlled study to assess 5% imiquimod cream for the treatment of multiple AK. Arch Dermatol 2002; 138: 1498-1502.
38. Stanley MA. Mechanism of action of imiquimod. Papillomavirus Rep 1999; 10: 23-29.
39. Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial. J Am Acad Dermatol 2002; 47: 571-577.
40. Riendeau D, Percival MD, Brideau C, et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cycloxygenase-2. J Pharmacol Exp Ther 2001; 296: 558-566.
41. Wolf JE Jr, Taylor JR, Tschen E, et al. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001; 40: 709-713.
42. Rivers JK, Arlette J, Shear N, et al. Topical treatment of actinic keratoses with topical 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 2002; 246: 94-100.
43. Jarvis B, Figgitt DP. Topical 3.0% diclofenac in 2.5% hyaluronan gel: A review of its use in patients with actinic keratoses. Am J Clin Dermatol 2003; 4: 203-213.
44. Witheiler DD, Lawrence N, Cox SE, et al. Long-term efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratosis. Dermatol Surg 1997; 23: 191-196.
45. Sander CA, Pfeiffer Ch, Kligman AM, et al. Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 1997; 36: 236-238.
46. Edwards L. The interferons. Dermatol Clin 2001; 19: 139-146.
47. Jeffes EW. Levulan: The first approved topical photosensitizer for the treatment of actinic keratosis. J Dermatol Treat 2002; 13: S19-S23.
48. Rossi R, Mavilia L, Ghersetich I, et al. Photodynamic therapy of actinic keratoses with methyl-aminolevulinate (Metvix). G Ital Dermatol Venereol 2005; 140: 381-387.
49. Rossi R, Lotti T, Cappugi P, et al. Guidelines for photodynamic therapy in dermatology: Treatment protocol. G Ital Dermatol Venereol 2005; 140: 637-644.
50. Cappugi P, Campolmi P, Mavilia L, et al. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: A minireview. J Chemother 2001; 13: 494-502.
51. Diffey BL. Sun protection with clothing. Editorial comments. Br J Dermatol 2001; 144: 449-450.